NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
school
University Rankings
subject
University Subject Rankings
place
Country Rankings
insights
i10 Productivity Rankings
insights
Subject Rankings
format_list_numbered
Top 100 Scientists
format_list_numbered
Citation Rankings
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
Hidenori Kitai
AD Scientific Index 2024
Others
Memorial Sloan Kettering Cancer Center - Montvale / United States
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Hidenori Kitai's MOST POPULAR ARTICLES
1-)
Epithelial-to-Mesenchymal Transition Defines Feedback Activation of Receptor Tyrosine Kinase Signaling Induced by MEK Inhibition in KRAS-Mutant Lung CancerEMT Defines RTK …H Kitai, H Ebi, S Tomida, KV Floros, H Kotani, Y Adachi, S Oizumi, ...Cancer discovery 6 (7), 754-769, 20161312016
2-)
Epithelial-to-mesenchymal transition antagonizes response to targeted therapies in lung cancer by suppressing BIMKA Song, MJ Niederst, TL Lochmann, AN Hata, H Kitai, J Ham, KV Floros, ...Clinical Cancer Research 24 (1), 197-208, 2018732018
3-)
Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expressionH Kotani, H Ebi, H Kitai, S Nanjo, K Kita, TG Huynh, A Ooi, AC Faber, ...Oncogene 35 (27), 3587-3597, 2016352016
4-)
Key roles of EMT for adaptive resistance to MEK inhibitor in KRAS mutant lung cancerH Kitai, H EbiSmall GTPases 8 (3), 172-176, 2017332017
5-)
Distinct dependencies on receptor tyrosine kinases in the regulation of MAPK signaling between BRAF V600E and non-V600E mutant lung cancersH Kotani, Y Adachi, H Kitai, S Tomida, H Bando, AC Faber, T Yoshino, ...Oncogene 37 (13), 1775-1787, 2018292018
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept